Literature DB >> 10767118

Thrombin: Structure, Biochemistry, Measurement, and Status in Clinical Medicine.

.   

Abstract

Thrombin remains a molecule of great interest to scientists and clinicians alike because of its important role in hemostasis, thrombosis, inflammation and vascular remodeling. Yet one of the great challenges has been the inhibition of thrombin generation to a degree that minimizes intravascular thrombosis while preserving physiologic hemostasis. It has become increasingly clear that high levels of anticoagulation with either direct or indirect thrombin antagonists are not beneficial and, in fact, are quite detrimental. Despite the overwhelming shift of interest toward the platelet in clinical trials of acute coronary syndromes, much can be gained through further investigation of coagulation processes responsible for thrombin generation and activity.

Entities:  

Year:  1998        PMID: 10767118     DOI: 10.1023/A:1008843925851

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  68 in total

1.  Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals.

Authors:  F W Sellke; J E Quillen; L A Brooks; D G Harrison
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

2.  Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.

Authors:  A W Haider; F Andreotti; G R Thompson; C Kluft; A Maseri; G J Davies
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

Review 3.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes.

Authors:  K G Mann; M E Nesheim; W R Church; P Haley; S Krishnaswamy
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

4.  Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis.

Authors:  P R Eisenberg; L Sherman; M Rich; D Schwartz; K Schechtman; E M Geltman; B E Sobel; A S Jaffe
Journal:  J Am Coll Cardiol       Date:  1986-06       Impact factor: 24.094

5.  Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction.

Authors:  A K Gash; J F Spann; S Sherry; A D Belber; B A Carabello; M T McDonough; R H Mann; W D McCann; J H Gault; R D Gentzler
Journal:  Am J Cardiol       Date:  1986-01-01       Impact factor: 2.778

6.  Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries.

Authors:  P J Pearson; H V Schaff; P M Vanhoutte
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

7.  Thrombin-catalyzed activation of single chain bovine factor V.

Authors:  M E Nesheim; K G Mann
Journal:  J Biol Chem       Date:  1979-02-25       Impact factor: 5.157

Review 8.  Thrombolysis in postinfarction angina.

Authors:  P Ouyang; E P Shapiro; S O Gottlieb
Journal:  Am J Cardiol       Date:  1991-09-03       Impact factor: 2.778

9.  Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.

Authors:  E J Haskel; S R Torr; K C Day; M O Palmier; T C Wun; B E Sobel; D R Abendschein
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

10.  Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial.

Authors: 
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

View more
  7 in total

1.  Competitive aptasensor with gold nanoparticle dimers and magnetite nanoparticles for SERS-based determination of thrombin.

Authors:  Ningjing Jiang; Tingfeng Zhu; Yongjun Hu
Journal:  Mikrochim Acta       Date:  2019-11-06       Impact factor: 5.833

2.  CdS quantum dots generated in-situ for fluorometric determination of thrombin activity.

Authors:  Laura Saa; Beatriz Díez-Buitrago; Nerea Briz; Valeri Pavlov
Journal:  Mikrochim Acta       Date:  2019-08-29       Impact factor: 5.833

3.  Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.

Authors:  Kevin Y Lin; Gabriel A Kwong; Andrew D Warren; David K Wood; Sangeeta N Bhatia
Journal:  ACS Nano       Date:  2013-09-12       Impact factor: 15.881

4.  Determination of FVIIa-sTF Inhibitors in Toxic Microcystis Cyanobacteria by LC-MS Technique.

Authors:  Andrea Roxanne J Anas; Anna Nakajima; Chiaki Naruse; Mineka Tone; Hirohiko Asukabe; Ken-ichi Harada
Journal:  Mar Drugs       Date:  2015-12-30       Impact factor: 5.118

5.  A Non-Label and Enzyme-Free Sensitive Detection Method for Thrombin Based on Simulation-Assisted DNA Assembly.

Authors:  Yingying Zhang; Luhui Wang; Yanan Wang; Yafei Dong
Journal:  Sensors (Basel)       Date:  2018-07-06       Impact factor: 3.576

6.  Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers.

Authors:  Andrew D Warren; Shonda T Gaylord; Kevin C Ngan; Milena Dumont Milutinovic; Gabriel A Kwong; Sangeeta N Bhatia; David R Walt
Journal:  J Am Chem Soc       Date:  2014-09-23       Impact factor: 15.419

7.  Development and Optimization of a Thrombin Sandwich Aptamer Microarray.

Authors:  Anna Meneghello; Alice Sosic; Agnese Antognoli; Erica Cretaio; Barbara Gatto
Journal:  Microarrays (Basel)       Date:  2012-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.